Acer Therapeutics Inc.·4

Jul 28, 9:00 AM ET

Schelling Chris 4

4 · Acer Therapeutics Inc. · Filed Jul 28, 2020

Insider Transaction Report

Form 4
Period: 2020-07-24
Schelling Chris
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2020-07-24$3.50/sh+142,857$500,0001,892,857 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION